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Summary.-Serum obtained by clotting whole blood contains a potent mitogen with
apparent specificity for mesenchymal cells. This peptide wound-healing hormone,
derived from platelets, is known as platelet-derived growth factor (PDGF). Serum
obtained by clotting plasma contains no detectable growth-promoting activity for
fibroblasts, and is therefore a valuable additive to culture medium for an examination
of the autonomy of cells from exogenous PDGF. Fibroblasts from man, mouse and
hamster remain mitotically quiescent in plasma-derived serum and proliferate only
when a source of PDGF is added. Normal human kidney epithelial cells and human
T-cells proliferate normally in plasma-derived serum, and are unaffected by the
addition of PDGF.
A range of virally transformed cells and malignant cells from chemically induced
rodent sarcomas was tested for their proliferative capacity in plasma-derived serum
and their response to exogenous PDGF. A complete spectrum of PDGF-dependence
was revealed. Polyoma-transformed BHK21 cells and SV40-transformed 3T3 cells
showed complete PDGF independence. Cells from 7 chemically induced rat or mouse
sarcomas provided results which ranged from the FS6 (a C57BL Cbi mouse sarcoma
which was completely PDGF dependent) to MC28 (a hooded rat sarcoma) which was
completely PDGF independent. The dependence of proliferation of these cells on
PDGF showed a close correlation with several features of their in vivo behaviour.
Tumours which were non-immunogenic in syngeneic hosts, contained few host
macrophages and produced a high incidence of spontaneous distant metastases
provided PDGF-independent cells. Cells from highly immunogenic, macrophage-
rich "non-metastasizing" tumours were on the other hand PDGF dependent and
tumours of intermediate "malignancy" provided cells with partial autonomy from
PDGF.
An assay for anchorage-independent growth provided data which also correlated
with autonomy from PDGF. However, daily addition of large amounts of PDGF to
BHK21 C13 cells induced reversible anchorage independent growth. The value of
plasma-derived serum for the investigation of the proliferative autonomy of malig-
nant cells is emphasized.
DtTRING CLOTTING, platelets release a platelets, and remain quiescent for long
potent mitogenic hormone with specificity periods. The subsequent addition ofnano-
for cells of mesodermal origin such as molar amounts of purified PDGF initiates
fibroblasts and smooth-muscle cells. This proliferation of such quiescent cultures.
polypeptide, known as platelet-derived Density-dependent inhibition of growth
growth factor (PDGF) is thought to play of normal mesodermal cells can be attri-
an important role in vivo in wound healing buted to exhaustion ofPDGF from serum,
(see review by Scher et al., 1979). Normal as it can be reversed by the addition of
fibroblasts will not proliferate in medium PDGF (Vogel et al., 1980).
containing serum clotted in the absence of Transformation ofnormal fibroblasts by
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oncogenic viruses such as SV40 reduces
their requirements for exogeneous PDGF,
and the loss of PDGF dependence appears
to correlate with their in vivo tumori-
genicity (Scher et al., 1978). Furthermore,
the capacity of these transformed cells to
proliferate under conditions of serum
restriction, and the relative absence of
density-dependent growth inhibition in
their cultures, reflects their decreased
requirement for serum growth factors.
We describe here a series ofexperiments
designed to examine the proliferative
capacity of a series of normal, malignant
(chemically induced) and virally trans-
formed cells in culture medium depleted of
PDGF, which reveals a relationship be-
tween the malignant phenotype of such
cells and their proliferative dependence
upon an exogenous source of PDGF.
MATERIALS AND METHODS
Cells
The cells studied are listed in Table I. They
were all adapted to grow in RPM1 1640
containing 15% foetal bovine serum (FCS),
25mM HEPES and antibiotics. They were
maintained at 37°C in 5% CO2 in humid air
as monolayer cultures, and were passaged
frequently (using 041% trypsin) to maintain
exponential growth. All cell lines were studied
within 20 passages, and cultures were re-
Cells
BHK21 C13
BHK21 C13-PyY
3T3-K and
SV40-3T3
Detroit 550
NK66
C57BL NLF1
FS6
FS6M,
FS29
MC24
HSN-TC
HSN
MC28
Normal human
lymphocytes
plenished from low passage stocks maintained
in liquid N2. They were routinely screened for
mycoplasma contamination by fluorescence
methods using Bisbenzimide H33258 (Chen,
1977) and were negative throughout these
studies. The mouse and rat tumour lines were
all shown at various times to be tumorigenic
in syngeneic hosts.
Sera
Whole blood serum (WBS).-20ml volumes
of venous blood were taken from normal
human volunteers and allowed to clot in
plastic universal bottles containing glass
beads. After clot retraction (37°C for 2 h)
the serum was removed and heated to 56°C
for 30 min and stored over liquid TN2.
Plasma-derived serum (PDS).-Similar vol-
umes of blood were collected into chilled
plastic universal bottles and these were then
centrifuged at 4°C at 1000 g for 7 min. The
plasma was then removed with a siliconized
pipette and recentrifuged at 1000 g for 7 min.
The plasma was then added to a universal
bottle containing glass beads and allowed to
clot at 37°C for 2 h. The fibrin clot was then
removed by centrifugation and the PDS
heated at 56°C for 30 min before storage over
liquidN2. WBS andPDSweretherebyexposed
to very similar conditions during preparation.
Platelet extracts
Time-expired platelet preparations were
obtained from the Haematology Department,
Royal Marsden Hospital. The platelets were
TABLE I.-List of cells used in these experiments
Description
"Normal" and polyoma virus-transformed baby
hamster kidney
"Normal" and SV40 virus-transformed mouse
fibroblasts
Normal human fibroblast
Normal human kidney epithelial cell
Normal mouse lung fibroblast
Benzo(a)pyrene-induced mouse (C57BL Cbi) sarcoma
Metastatic variant ofFS6
Benzo(a)pyrene-induced C57BL Cbi sarcoma
Methylcholanthrene-induced hooded rat sarcoma
Benzo(a)pyrene-induced hooded rat sarcoma subline
Parent line ofHSN-TC
Methylcholanthrene induced hooded rat sarcoma
Ficoll-Hypaque separated mononuclear cell
suspensions
Origin
Flow Labs Ltd
Dr. L. Franks
ICRF Laboratories, London
Flow Labs Ltd
Home grown
Home grown
Home grown
Home grown
Home grown
Home grown
Home grown
Home grown
Home grown
Normal healthy volunteers
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centrifuged at 1500 g for 20 min at 4°C and
washed in 2 changes of acid citrate dextrose
(ACD). The platelets from 5-10 u of blood
were resuspended in 3 ml of phosphate-
buffered saline (PBS) and rapidly frozen
(using solid CO2 and ethanol). They were then
allowed to thaw and placed in a boiling water
bath for 10 min. The precipitate was removed
by centrifugation and the clear supernatant
was dialysed overnight against PBS. It was
then passed through a millipore 0-22/um
filter and stored over liquid N2. Since boiling
removed most of the protein from these
extracts the levels ofprotein were too low for
conventional measurement. Batches of plate-
let extract were assayed in serial dilution on
BHK21 C13 cells cultured in 15% PDS. One
unit of growth factor was defined as the
amount of platelet extract which produced
50% of maximal growth, assayed after 48 h
exposure.
Cell proliferation assay.-This assay is a
modification of the methylene-blue assay
described by Martin et al. (1978). Cells were
obtained from stock cultures by trypsiniza-
tion and added in 100l,x volumes to the wells
of Microtest II plates (Falcon) using a
Titertek 8-channel dispenser. To each well
was added 1-5 x 103 cells (depending on the
plating efficiency of the individual cell lines).
The medium used was RPMI 1640 plus
HEPES and antibiotics, containing 15%
WBS or PDS. After 6-8h incubation at
37TC, when the cells had stuck and spread,
one replicate plate was harvested and referred
to as "time 0". Other plates were harvested
at daily intervals thereafter.
For harvesting, the plates were slowly
immersed in a tank ofPBS at room tempera-
ture at an angle of - 300 from the horizontal
and then gently inverted and the wells
drained by placing on a sheet ofdamp sponge
(F. W. Woolworth).
This procedure was performed 3 times and
then, to each well, 100 jzd of5% formol-saline
were gently added. This gentle wash and fixa-
tion method produced no morphologically
observable damage to cell monolayers. The
cells were fixed for 30 min, when the formol-
saline was removed by a flick of the wrist.
To each well was then added 100 ,ul of 1%
methylene blue in O-O1M borate at pH 8-5.
The cells were stained for 30 min and the dye
removed with another flick of the wrist.
The plate was then thoroughly washed in 3
changes of borate buffer, inverted on to a
stack of paper tissue and allowed to dry.
When dry, 0-1 ml of 0*1N HC1 was added to
each well to elute the dye from the cells, and
the plate was left for 10 min before gentle
agitation by lateral shaking to mix the dye
uniformly in each well.
The under surface of the plate was then
carefully cleaned and read in a Multiskan
(Titertek). This vertical path 8-channel
spectrophotometer was used with an inter-
ference filter at 650 nm and provided print-
outs of optical density for each well of a
96-well plate. The Multiskan was blanked on
the first row of wells, which in each plate
contained the appropriate medium but no
cells. Theresults wereexpressed asabsorbance
at 650 nm (A650). All experiments were per-
formed in sextuplicate, and since this method
provides extremely constant replicates, the
error bars in the figures represent the total
spread for 6 observations.
Anchorage-independent growth.-Cells ob-
tained from stock cultures were seeded in
complete medium containing 1.2% methyl-
cellulose (Methocel A4M) into triplicate
60mm plastic dishes at 103 and 104 cells per
dish. The dishes contained a thin coating
(2 ml per dish) of 0-9% low-gelling-tempera-
ture agarose in complete medium. After
plating, any dish with clumped cells was
discarded.
After incubation for 14 days the number of
observable colonies was counted under a low-
power stereo microscope; only "large" colo-
nies were counted, i.e. colonies judged to
contain >50 cells. The results are presented
as "plating efficiencies", i.e. the number of
observable colonies as a percentage of the
number ofcells added per dish.
RESULTS
Growth of normal cells in PDS vs WBS
BHK21 C13 were used in many ofthese
studies. These untransformed baby ham-
ster kidney cells proliferated rapidly in
15% WBS. However, when cultured in
15% PDS they failed to divide (see Fig. 1).
The addition of platelet extract to such
cultures in PDS, however, readily stimu-
lated proliferation.
Similar results were obtained with
3T3K mouse cells, Detroit 550 human
fibroblasts and NLF1 mouse fibroblasts;
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FIG. 1.-Growth of BHK21 C13 cells in
plasma-derived serum (*0-0) and in
whole-blood serum (0-0). A650 absorb-
ance of cell-bound methylene-blue meas-
ured at 650 mm using a Multiskan
8-channel photometer. Error bars indicate
data spreads for sextuplicate cultures.
i.e. normal mesenchymal cells from 3
species show absolute dependence of pro-
liferation on a source of PDGF (Table II).
Effect of platelet extract on BHK21 C13
cells inPDS
When serial dilutions ofplatelet extract
were added to BHK21 C13 cells in 15%
PDS it was found that this preparation
has substantial mitogenic activity on
these cells down to low concentrations.
When time-course studies were done in
combination with such a dose-response
curve, we were able to plot (Fig. 2) the
effect of platelet extract on cell popula-
tion-doubling time (CPDT) which shows
that CPDT in these cultures reflects the
availability of environmental growth
factor.
TABLE II.-Population-doubling times of
normal, virus-transformed and chemically
induced sarcoma cells cultured inplasma-
derived serum (PDS) with and without
platelet extract. The difference in doubling
times (with and without the platelet
extract) reflects the extent ofdependence on
this growthfactor
Population-
doubling time (h)
Cells
BHK21 C13
BHK21 C13-PyY
3T3-K
SV40-3T3
Detroit 550
NK66
C57BL NLF1
FS6
FS6M1
FS29
MC24
HSN-TC
HSN
MC28
In PDS*
96-0
11-6
> 100
9-4
> 100
28-0
> 100
> 100
32-4
43-0
> 100
55-4
28-3
18-4
In PDS
+ 1: 100
PEt
11-0
11 6
9 2
9.3
14-0
28-0
15.1
30-0
32-4
29-0
13-6
22-0
23-3
18-4
Differ.
ence
(h)
85-0
0
> 88-0
0-1
> 86-0
0
> 84-9
>70-0
0
14-0
> 86-4
33-4
5-0
0
* PDS=Plasma-derived serum (15%
t PE =Platelet extract.
Growth of normal and malignant cells in
PDS
We examined the various cell types
listed in Table I for their ability to grow
in PDS. The results are shown in Table II,
and some are illustrated in Figs 3 and 4.
By examining the doubling time ofcells in
PDS with and without a standard con-
centration of exogenous platelet extract
(1:100) a figurereflectingtheirdependence
on PDGF was derived from the difference
in doubling times in the two culture con-
ditions. No difference in doubling time
implies absolute independence, whereas a
difference reflects the extent of PDGF-
dependence.
The results show, as mentioned above,
that the normal mesodermal cells ex-
amined (BHK21 C13, 3T3K, NLF1 and
Detroit 550) do not proliferate in PDS,
but do so when platelet extract is added.
Normal lymphocytes responded to PHA
as well in PDS as in WBS, and platelet
extract did not affect their response.
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Fie-,. 2.-Population-doubling time of BHK21
C13 and the effect of adding incrieasing
amounts of human platelet extract.
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Fi(;. 3. Proliferation of BHK21 C1 3 cells
in plasma-derived seirum (0 0) and
the effect of adding 1: 100 platelet extract
(0 0). The transformed cell BHK21
Cl13-PyY showed identical gIrowth in P'DS
vith and without, addedc platelet extract
(- *).
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FIG. 4.-Proliferation of FS29 sarcoma cells
in plasma-derived serum (0 0) and the
effect of 1: 100 platelet extract (0-0).
The HSN sarcoma cells proliferated in
plasma-derived serum (0 - - 0) and
showed a smaller response to 1:100 platelet
extract (0 0).
NK66, a human epithelioid renal cell, pro-
liferated just as well in PDS as in WBS,
and showed no response to platelet extract.
which supports the view that PDGF
mitogenic activity is restricted to mesen-
chymal cells such as fibroblasts.
Virally transformed cells, SV40-3T3
and BHK21 C13-PyY, grew well in PDS
without exogenous platelet extract (i.e.
they are absolutely independent of ex-
ogenous PDGF) and the addition of
exogenous platelet extract had no effect
on their rate of growth. The remaining
malignant cells, all of mesodermal origin,
showed a range of dependence on PDG(F
(see Table III).
FS6, a C57BL Cbi mouse chemically
induced fibrosarcoma, required a source of
exogenous PDGF whereas a spontaneous
subline, FS6 MI, is completely PDGF
independent. The FS6 is highly immu-
nogenic in syngeneic hosts, contains large
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TABLE III.-Chemically induced sarcomas
of rats and mice, a comparison of their
macrophage content in vivo, their capa-
citiesfor spontaneous metastases and their
dependence upon platelet-derived growth
factor in vitro
TABLE IV.-Colony formation in methyl-
cellulose-containing medium, a measure
of anchorage-independent growth. Note
that the repeated addition of platelet ex-
tract to cultures ofBHK21 C13fibroblasts
results in anchorage-independent growth
Tumour
FS6
MC24
FS29
HSN-TC
HSN
FS6M1
MC28
Average
macrophage Spontaneous
content ( %)* metastasist
48+9
33+5
21+7
23+5
17+5
6+4
5+2
+
+
++
Depend
on plai
factoI
++
++
+
+
* Assessed by the method of Evans (1972). The
figures represent the means from 5 tumours of
each type.
t Arbitrary assessment of metastatic behaviour
based on data provided by S. Heckford and S.
Eccles.
numbers of macrophages and rarely
gives rise to distant metastases. The FS6
MI variant line, however, contains few
macrophages, is feebly immunogenic and
rapidly gives rise to distant metastases.
In the remaining tumour lines FS29
(C57BL Cbi mouse sarcoma), MC24, HSN,
HSN-TC, and MC28 (hooded rat fibro-
sarcomas) this apparent correlation is
maintained (i.e. cells from tumours which
are the most feebly immunogenic and
rapidly metastatic are the least PDGF
dependent).
Anchorage-independent growth and PDGF
dependence
As shown in Table IV the normal fibro-
blast cell lines provided very low colony
formation; i.e. they show anchorage-
dependent growth. All the malignant or
virus-transformed cells tested showed sig-
nificant anchorage-dependent growth.
BHK21 C13 cells under these conditions
provided a very low plating efficiency
( < 0-001%). Replicate dishes ofthese cells
were also treated with platelet extract.
About 5 units of platelet extract (in 25p1
PBS) were added to the dishes each day
for 14 days. Control dishes received PBS.
After 14 days the dishes treated with this
massive excess of platelet extract con-
lence
ftolet Cells tested
r
UU U
BHK21 C13
Detroit 550
+ CTC-K
+ BHK21 C13-PyY
+ SV40-3T3
+ FS6
+ FS6M1
- HSN
- MC28
BHK21 C13 Dlus excess Dlatelet extract
PE %*
<0-001
<0-001
< 0-001
17-2
11-0
003
3-6
3.9
14-1
7-1
* PE =No. of colonies formed/No. of cells plated
x 100.
tained increased numbers of large colonies
(a plating efficiency of 7*1%). The con-
tinuous administration of this particular
growth factor conferred upon these cells a
phenotypic characteristic of transformed
cells, i.e. anchorage-independent growth.
However, this effect is reversible, depend-
ent upon a continuous supply of platelet
extract. Monolayer cultures of BHK21
C13 cells were similarly treated with plate-
let extract for 14 days. This produced
massively overgrown super-confluent
multilayered cultures. After trypsinization
and subculture, however, these cells re-
tained their absolute dependence on
PDGF, i.e. they failed to proliferate in
PDS (data not shown).
DISCUSSION
These observations confirm those of
Ross et al. (1978) that normal (untrans-
formed) cells of mesodermal origin fail to
proliferate when cultured in medium
containing serum obtained by clotting
plasma. The addition of serum obtained
by clotting whole bloodin the conventional
manner, caused these cells to proliferate
rapidly, as did an extract of human plate-
lets. This platelet-associated activity first
described by Ross et al. (1974) has been
attributed by Antoniades & Scher (1977)
to a heat-stable polypeptide with an iso-
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electric point of 9-8, a mol. wt , 13,000,
which is present in platelet of granules. It
is released during clotting and is present
in high concentrations in serum but rela-
tively absent from plasma.
In the absence of platelet-derived
growth factor (PDGF) normal mesen-
chymal cells become arrested in Go. The
addition of very low concentrations of
platelet extract or purified PDGF initiates
exit from Go and proliferation ensues.
Stiles et al. (1979) have shown that PDGF
confers upon BALB/c 3T3 cells "compe-
tence" to synthesize DNA when exposed
to other factors in PDS such as the
somatomedins; i.e. fibroblast mitogenesis
seems to require two distinct signals. Scher
et al. (1979) regard PDGF as a polypeptide
hormone, since it is an informational
molecule carried in the blood which acts
at nanomolar concentrations on specific
target cells. Since platelets adhere to
injured tissues they provide a packaged
delivery system for this potent wound-
healing hormone.
Under normal in vivo conditions PDGF
is confined to intracellular sites (of granules
of platelets): the quiescence of normal
mesenchymal cells such as fibroblasts or
smooth-muscle cells reflects the absence
of exogenous mitogenic stimuli, rather
than any hypothetical negative feedback
such as "chalones". Proliferation of such
cells seems to be an adaptive response to a
specific humoural signal rather than an
intrinsic cellular property which requires
direct negative cybernetic control. Fur-
thermore, when BHK21 C13 cells are
grown in tissue culture their population-
doubling time is a function of the dose of
platelet factor added. Ross et al. (1978)
attribute this to a dose-related recruit-
ment of cells into the cell cycle.
PDGF appears to show no species
specificity. We have detected mitogenic
activity of human platelet extract on
normal mesodermal cells from man, ham-
ter and mouse. Furthermore, platelet
extract derived from normal sheep was
active on human, hamster and mouse
fibroblasts (unpublished observations). In
our hands, human PDGF has no effect on
human normal epithelial cells, which grow
well in PDS. Human lymphocytes show
normal lectin responses when cultured in
either PDS or WBS, and are unaffected by
the addition of PDGF. Further studies
will be needed to define clearly its pattern
of cellular specificity. However, our data
indicate, like those of Ross et al. (1978),
that the mitogenic activity of PDGF is
restricted to cells of mesenchymal origin.
When injected s.c. in polyacrylamide
beads, semi-purified PDGF induced dram-
atic fibroblast proliferation (unpublished
observations).
Scher et al. (1978) have shown that
transformation of 3T3 cells with SV40
reduces their requirement for exogenous
PDGF. Furthermore, they described a
close correlation between the in vivo
tumorigenicity of cells and their capacity
to proliferate in vitro in the absence of
exogenous PDGF. In their studies the
viral transforming gene seems to allow the
cells to acquire autonomy from this
specific mitogenic hormone. Brown &
Holley (1979) have, however, described a
benzo(a)pyrene-transformed line of 3T3
cells which shows "normal" responses to
growth factors. Growth factor autonomy
does not, therefore, appear to be a sine qua
non of the transformed state. These im-
portant findings led us to examine depend-
ence on exogenous PDGF to determine
whether there was any correlation be-
tween malignant phenotypic behaviour
and autonomy from PDGF. Four different
normal (i.e. untransformed) mesenchymal
cells (BHK21 C13, 3T3-K, Det-550,
C57BL NLF1) showed no evidence of
proliferation when cultured in 15% PDS.
Occasional batches ofPDS did allow some
proliferation of all 4 lines, but following
elution from a CM-Sephadex C-50 column
the serum was totally depleted of mito-
genic activity (data not shown). The re-
maining cell lines were then tested in
batches of PDS shown to produce com-
plete quiescence in BHK21 C13 cells.
Virally transformed cells, SV40-3T3 and
BHK21 C13-PyY, grew equally well in
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PDS or WBS, and were unaffected by the
addition ofplatelet extract (i.e. they show
complete PDGF-independence). Seven rat
and mouse chemically induced sarcoma
cell lines, mycoplasma-free and tumori-
genic in syngeneic animals, were then
examined for their dependence on ex-
ogenous platelet factor. They presented a
complete spectrum of dependence, which
correlated with several features of their
behaviour in vivo. The cells from tumours
which are feebly immunogenic and which
show a high degree of spontaneous meta-
stasis grew well in the absence of PDGF
(e.g. FS6M1, MC28). The FS6 sarcoma is
highly immunogenic in vivo and rarely
metastasizes. In vitro its cells resemble
normal fibroblasts, in that they require a
source of exogenous PDGF (i.e. they fail
to proliferate in vitro in PDS). Tumours
such as the FS29, HSN and HSNTC
showed intermediate properties in vivo,
and in tissue culture showed low growth
rates when cultured in PDS and enhanced
proliferation when PDGF was added.
The most striking finding was the differ-
ence between the FS6 and its metastatic
subline FS6M1. The metastatic subline
grew well in PDS without exogenous
platelet extract. In other words the
acquisition of mitotic autonomy from
PDGF may be associated with increased
malignant behaviour. Further studies of
this pair of tumour cell lines will be pub-
lished separately.
There was also a correlation between
anchorage-independent growth (i.e. the
capacity to produce col0nies in methyl-
cellulose-containing medium in the pre-
sence of 15% FCS) and capacity to grow
in PDS. Cells whose proliferation was com-
pletely PDGF independent readily pro-
duced large colonies. However, BHK21
C13, the normal untransformed line of
hamster fibroblasts, although providing
very low colony numbers in conventional
medium, produced large numbers of
colonies when repeatedly exposed to high
concentrations of platelet extract. This
acquisition of an alleged phenotypic
characteristic ofmalignant transformation
was reversible. Anchorage-independent
growth, however, is not a sine qua non of
the malignant phenotype, since normal
marrow cells and even lymphocytes can
readily form colonies under these con-
ditions when suitable growth-promoting
stimuli are added (Burgess et al., 1977).
The apparent correlation between the
malignant potential of a cell and its
autonomy from a tissue-specific mitogenic
hormone may represent an important
feature of neoplastic progression. Those
tumour cells studied could represent
various stages in the spectrum of discon-
tinuous phenotypic changes leading to the
end-stage autonomous highly metastatic
cell. The possible role of "autocrine
secretion" as suggested by Sporn and
Todaro (1980) as one mechanism respons-
ible for the unrestrained proliferation of
transformed cells is being investigated
and will be reported separately. The
capacity to induce quiescence in normal
mesenchymal cells by the use of PDS
appears to be a valuable technique for the
investigation of mitotic autonomy asso-
ciated with malignant transformation.
These studies are supported by a programme grant
from the Medical Research Council. I thank the
Cancer Research Campaign for financial support.
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